Piramal Enterprises To Raise Up To Rs 2,750 Cr Via Bonds

Piramal Enterprises said the money can be raised in one or more tranches from time to time

Risky Bet Of An Indian Fund House

After Piramal Healthcare sold its India formulation business to Abbott in 2010 for $3.7 billion, the group toyed with several ideas to re-deploy the money. But chairman Ajay Piramal was clear about the new business he wanted to get into. Financial services

Collaboration Can Lead Us To Better Discovery

Drug discovery has changed. The model of big pharma retaining all the knowledge within has become obsolete

Piramal To Acquire Janssen’s Criticare Brands For $175 Million

The products to be acquired are five injectable versions of well-established Janssen brands, Sublimaze, Sufenta, Rapifen, Dipidolor and Hypnomidate

Piramal Healthcare Makes Fresh Investment In Scottish Unit

The company has been growing its operations in Grangemouth since 2005 and currently employs around 140 people in predominantly highly skilled positions. ,C H Unnikrishnan reports

Drug Makers Go Off-Roading

In India, Gift-Giving Drives Drugmakers Marketing

So Near, Yet So Far

Death Of A Dream

Piramal To Buy US Drug Data Firm For $635 Mn

Piramal Adds To His Empire

Piramal's Revenue Potential From Florbetaben

Abbott, Biocon to develop nutrition products for India

Mother, Sons And A Dream

Premium Selling